Konrath_2013_J.Pharm.Pharmacol_65_1701

Reference

Title : Alkaloids as a source of potential anticholinesterase inhibitors for the treatment of Alzheimer's disease - Konrath_2013_J.Pharm.Pharmacol_65_1701
Author(s) : Konrath EL , Passos Cdos S , Klein-Junior LC , Henriques AT
Ref : J Pharm Pharmacol , 65 :1701 , 2013
Abstract :

OBJECTIVES: The inhibition of acetylcholinesterase (AChE), the key enzyme in the breakdown of acetylcholine, is currently the main pharmacological strategy available for Alzheimer's disease (AD). In this sense, many alkaloids isolated from natural sources, such as physostigmine, have been long recognized as acetyl- and butyrylcholinesterase (BChE) inhibitors. Since the approval of galantamine for the treatment of AD patients, the search for new anticholinesterase alkaloids has escalated, leading to promising candidates such as huperzine A. This review aims to summarize recent advances in current knowledge on alkaloids as AChE and BChE inhibitors, highlighting structure-activity relationship (SAR) and docking studies. KEY FINDINGS: Natural alkaloids belonging to the steroidal/triterpenoidal, quinolizidine, isoquinoline and indole classes, mainly distributed within Buxaceae, Amaryllidaceae and Lycopodiaceae, are considered important sources of alkaloids with anti-enzymatic properties. Investigations into the possible SARs for some active compounds are based on molecular modelling studies, predicting the mode of interaction of the molecules with amino acid residues in the active site of the enzymes. Following this view, an increasing interest in achieving more potent and effective analogues makes alkaloids good chemical templates for the development of new cholinesterase inhibitors. SUMMARY: The anticholinesterase activity of alkaloids, together with their structural diversity and physicochemical properties, makes them good candidate agents for the treatment of AD.

PubMedSearch : Konrath_2013_J.Pharm.Pharmacol_65_1701
PubMedID: 24236981

Related information

Citations formats

Konrath EL, Passos Cdos S, Klein-Junior LC, Henriques AT (2013)
Alkaloids as a source of potential anticholinesterase inhibitors for the treatment of Alzheimer's disease
J Pharm Pharmacol 65 :1701

Konrath EL, Passos Cdos S, Klein-Junior LC, Henriques AT (2013)
J Pharm Pharmacol 65 :1701